Literature DB >> 21640757

Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.

Rolf Jorde1, Guri Grimnes.   

Abstract

Considering that the vitamin D receptor as well as the 1-α-hydroxylase enzyme that converts 25-hydroxyvitamin D (25(OH)D) to its active form 1,25-dihydroxyvitamin D have been found in tissues throughout the body, it is likely that vitamin D is important for more than the calcium balance. Accordingly, low serum levels of 25(OH)D have been associated with mortality, cardiovascular disease, type 2 diabetes, hypertension and obesity. Low serum levels of 25(OH)D have also been associated with an unfavourable lipid profile, which could possible explain the relation with cardiovascular disease and mortality. However, the relation between vitamin D and lipids have so far received little attention and is therefore the main focus of the present review. A PubMed search identified 22 cross-sectional studies where serum levels of 25(OH)D and lipids were related and that included a minimum of 500 subjects, and 10 placebo-controlled double-blind intervention studies with vitamin D where more than 50 subjects were included. In all the cross-sectional studies serum 25(OH)D was positively associated with high-density lipoprotein cholesterol (HDL-C) resulting in a favourable low-density lipoprotein cholesterol (LDL-C) (or total cholesterol) to HDL-C ratio. There was also a uniform agreement between studies on a negative relation between serum 25(OH)D and triglycerides (TG). On the other hand, the intervention studies gave divergent results, with some showing a positive and some a negative effect of vitamin D supplementation. However, none of the intervention studies were specifically designed for evaluating the relation between vitamin D and lipids, none had hyperlipemia as an inclusion criterion, and none were sufficiently powered. In only one study was a significant effect seen with an 8% (0.28 mmol/L) increase in serum LDL-C and a 16% (0.22 mmol/L) decrease in serum TG in those given vitamin D as compared to the placebo group. Accordingly, the effect of vitamin D supplementation on serum lipids is at present uncertain. Considering the numerous other promising vitamins and minerals that when properly tested have been disappointing, one should wait for the results of forthcoming vitamin D intervention studies before drawing conclusions on potential beneficial effects of vitamin D.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640757     DOI: 10.1016/j.plipres.2011.05.001

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  105 in total

1.  Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.

Authors:  Huicui Meng; Nirupa R Matthan; Edith Angellotti; Anastassios G Pittas; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

2.  Better Body Composition and Lipid Profile Can Be Associated with Vitamin D Status in Spanish Elderly? The PHYSMED Study.

Authors:  W N Souza; R Aparicio-Ugarriza; M M Bibiloni; G Palacios; I Aguilar; J A Tur; M González-Gross
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol.

Authors:  Brian H Shirts; Michael T Howard; Sandra J Hasstedt; M Nazeem Nanjee; Stacey Knight; John F Carlquist; Jeffrey L Anderson; Paul N Hopkins; Steven C Hunt
Journal:  Atherosclerosis       Date:  2012-03-01       Impact factor: 5.162

Review 4.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

5.  Are Serum Levels of F2-Isoprostane and Oxidized-LDL Related to Vitamin D Status in Type 2 Diabetic Patients? A Case-Control Study.

Authors:  Mohammad Hassan Javanbakht; Hamed Mohammady; Koorosh Fooladsaz; Maryam Razzaghi; Mahnaz Zarei; Mahmoud Djalali
Journal:  Rep Biochem Mol Biol       Date:  2016-10

6.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

7.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

8.  Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hanne Hauger; Rikke Pilmann Laursen; Christian Ritz; Christian Mølgaard; Mads Vendelbo Lind; Camilla Trab Damsgaard
Journal:  Eur J Nutr       Date:  2020-02-14       Impact factor: 5.614

9.  Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

Authors:  John R Montford; Michel Chonchol; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Jessica Kendrick
Journal:  Am J Nephrol       Date:  2013-02-20       Impact factor: 3.754

10.  Levels of 25-hydroxyvitamin D3, biochemical parameters and symptoms of depression and anxiety in healthy individuals.

Authors:  Gleicilaine A S Casseb; Gabriela Ambrósio; Ana Lúcia S Rodrigues; Manuella P Kaster
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.